HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luiz Felipe Domingues Passero Selected Research

Luiz Felipe Domingues Passero Research Topics

Disease

7Leishmaniasis
06/2021 - 01/2018
4Infections
01/2014 - 04/2008
3Visceral Leishmaniasis (Kala Azar)
06/2021 - 12/2020
3Cutaneous Leishmaniasis
10/2020 - 04/2008
2Chromoblastomycosis (Chromomycosis)
10/2021 - 04/2020
1Tuberculosis (Tuberculoses)
05/2021

Drug/Important Bio-Agent (IBA)

4Amphotericin B (Amphotericin)FDA LinkGeneric
10/2020 - 01/2018
3AntigensIBA
12/2020 - 12/2010
3Pharmaceutical PreparationsIBA
01/2020 - 01/2018
2Imiquimod (Aldara)FDA LinkGeneric
10/2021 - 04/2020
2Ursolic AcidIBA
06/2021 - 10/2020
2LipidsIBA
06/2021 - 04/2008
1AcitretinFDA Link
10/2021
1Lipid NanoparticlesIBA
06/2021
1Antitubercular AgentsIBA
05/2021
1TriterpenesIBA
01/2021
1Pentacyclic TriterpenesIBA
01/2021
1Meglumine AntimoniateIBA
10/2020
1Muramidase (Lysozyme)IBA
01/2014
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2009
1Phospholipases A2 (Phospholipase A2)IBA
04/2008
1Interleukin-2 (IL2)IBA
04/2008
1Dinoprostone (PGE2)FDA Link
04/2008

Therapy/Procedure

2Therapeutics
10/2020 - 01/2018